Enalapril Maleate Prices June 2023
Product
|
Category |
Region |
Price |
Enalapril Maleate |
Pharma API |
USA |
81792 USD/MT |
Enalapril Maleate |
Pharma API |
China |
159743 USD/MT |
Enalapril Maleate |
Pharma API |
Germany |
176960 USD/MT |
The price of enalapril maleate in the USA for Q2 2023 reached 81792 USD/MT in June.
The price trend for enalapril maleate in China concluded at 159743 USD/MT in June 2023.
Moreover, Germany’s enalapril maleate prices stood at 176960 USD/MT during Q2 2023.
Enalapril Maleate Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Enalapril Maleate Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of enalapril maleate pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of enalapril maleate at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of enalapril maleate price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing enalapril maleate price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Enalapril Maleate Market Analysis
The global enalapril maleate market size reached US$ 540.5 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 845.8 Million, at a projected CAGR of 5.10% during 2023-2032.
- The market is experiencing significant growth driven by the rising prevalence of hypertension and cardiovascular diseases (CVDs) worldwide.
- An estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, however only less than half of adults (42%) are diagnosed and treated. Moreover, amongst these, approximately only 1 in 5 adults (21%) have it under control. Consequently, as lifestyle factors such as unhealthy diet, sedentary behavior, and stress become more prevalent, the incidence of hypertension continues to increase, thereby driving the demand for enalapril maleate.
- By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. This rise in the geriatric population is contributing to the market growth, as older individuals are more susceptible to hypertension and related conditions.
- In confluence with this, increasing awareness about the importance of early diagnosis and treatment of hypertension among both healthcare professionals and patients is creating a positive outlook for market expansion.
- Another factor supporting the market growth is the availability of generic versions of enalapril maleate at lower costs, making the medication more accessible, particularly in emerging economies where affordability is a significant concern.
- Significant advancements in pharmaceutical formulations and drug delivery technologies enhancing the efficacy and safety profile of enalapril maleate are presenting lucrative opportunities for market expansion.
- Concurrent with this, the growing adoption of enalapril maleate for off-label uses, such as in the management of diabetic nephropathy and chronic kidney disease, is providing an impetus to the market growth.
- Moreover, strategic collaborations and partnerships between pharmaceutical companies and healthcare providers are facilitating market penetration and distribution channels, thereby boosting the market growth.
- Besides this, the implementation of favorable government initiatives aimed at promoting cardiovascular health and reducing the burden of hypertension through public health campaigns and awareness programs is acting as another significant growth-inducing factor.
- Furthermore, the increasing healthcare expenditure in both developed and developing countries is fueling the demand for enalapril maleate, as patients seek access to affordable and effective treatments for hypertension and related conditions.
- Apart from this, the growing trend of telemedicine and remote patient monitoring creating new opportunities for market players to reach underserved populations and provide timely diagnosis and treatment for hypertension, are further propelling the market forward.
Enalapril Maleate News
The report covers the latest developments, updates, and trends impacting the global enalapril maleate market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in enalapril maleate production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the enalapril maleate price trend.
Latest developments in the enalapril maleate industry:
- In March 2023, Medichem, S.A, acquired a new facility at Parque Tecnológico de Asturias in Llanera. This facility will house a plant for the manufacture of injectable products that the company expects to have in operation by 2024.
- In the financial year 2023, The Dr. Reddy’s announced significant investments in research and development, amounting to INR 19.4 billion. This investment supports the development of new products, including Enalapril Maleate, to maintain a competitive edge and build a robust pipeline.
Product Description
Enalapril Maleate is a medication used to treat high blood pressure and congestive heart failure. It belongs to the angiotensin-converting enzyme (ACE) inhibitors class and relaxes blood vessels, facilitating smooth blood flow and enhancing the heart's ability to pump blood. This medicine is mostly taken orally, either with or without food, and is available in tablet form.
It is commonly prescribed for hypertension management, lowering blood pressure, and reducing the risk of heart attacks, strokes, and kidney problems. In congestive heart failure, it improves symptoms like shortness of breath and swelling in the legs. However, enalapril maleate is not recommended for use during pregnancy due to potential harm to the unborn baby and may interact with certain medications, so it is crucial to inform healthcare providers of all medications, supplements, and herbal products being taken.
Regional Coverage
The report provides a detailed analysis of the enalapril maleate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the enalapril maleate price trend.
Global Enalapril Maleate Price
The report offers a holistic view of the global enalapril maleate pricing trends in the form of enalapril maleate price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of enalapril maleate but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed enalapril maleate demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Enalapril Maleate Price
European enalapril maleate prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed enalapril maleate price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Enalapril Maleate Price
The analysis of enalapril maleate prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific enalapril maleate historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Enalapril Maleate Price
The report explores the enalapril maleate pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on enalapril maleate prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Enalapril Maleate Price
The enalapril maleate pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This enalapril maleate price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Enalapril Maleate Price
The analysis of enalapril maleate prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Enalapril Maleate |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Enalapril Maleate Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of enalapril maleate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting enalapril maleate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The enalapril maleate price charts ensure our clients remain at the forefront of the industry.